Evidence map›Paper›PMID 38833452›Full record

ArticlePLOS global public health2024

Implementation of gender-based violence screening guidelines in public HIV treatment programs: A mixed methods evaluation in Uganda.

Dorothy Thomas, Alisaati Nalumansi, Mira Reichman, Mine Metitiri, Florence Nambi, Joseph Kibuuka, Lylianne Nakabugo, Brenda Kamusiime, Vicent Kasiita, Grace K Nalukwago and 5 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dorothy ThomasDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0001-5510-5940
Alisaati NalumansiInfectious Diseases Institute, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0009-0005-2450-5083
Mira ReichmanDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Mine MetitiriDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Florence NambiInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Joseph KibuukaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Lylianne NakabugoInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Brenda KamusiimeInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Vicent KasiitaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Grace K NalukwagoInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Timothy R MuwongeInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Jane SimoniDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Elizabeth T MontgomeryWomen's Global Health Imperative, RTI International, Berkeley, California, United States of America.
Andrew MujugiraDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Renee HeffronDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0001-6039-0352

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIV and gender-based violence (GBV) intersect to threaten population health. The Uganda Ministry of Health recommends routine GBV screening alongside HIV care but evidence detailing its implementation in HIV care settings is limited. We evaluated screening practices in public HIV clinics to generate evidence supporting GBV screening optimization.

methodsTo evaluate GBV screening implementation in antiretroviral therapy (ART) clinics, we extracted client data from GBV registers at 12 public ART clinics in Uganda (January 2019-December 2021). We concurrently evaluated perceptions of GBV screening/referral practices by conducting in-depth qualitative interviews with providers (N = 30) and referral partners (N = 10). We contextualized quantitative findings with interview data which were analyzed using a thematic analysis approach.

resultsDuring the evaluation period, >90% of providers in participating health facilities implemented GBV screening. Among 107,767 clients served in public ART clinics, providers identified 9,290 (8.6%) clients who experienced past-year physical, sexual and/or emotional GBV of whom 86% received counseling and 19% were referred to support services-most commonly to legal services. Key factors influencing GBV screening implementation included awareness of screening guidelines; client volume; and client's level of engagement in HIV care. Providers and referral partners identified important benefits to clients (e.g., pursuit of justice and removal from violent environments) when referrals were successful. Key factors influencing referrals included financial constraints that limited referral partners' ability to provide services at no cost to clients and socio-cultural norms that inhibited client willingness to pursue support services.

conclusionsGBV screening implementation in ART clinics supports identification and referral of clients exposed to violence. The effectiveness of GBV screening may be limited by socio-cultural factors that inhibit client capacity to pursue referrals and fragmented and resource-constrained referral networks. Providers and referral partners identified allocating funds to support referrals and collaborative networking meetings as important opportunities for strengthening GBV referrals.

Identifiers

PMID38833452
PMCPMC11149855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.